| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ventyx Biosciences, Inc. (VTYX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. VTYX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.37M | $18.32M | - | |
| Other | 489.5K | $3.78M | - | |
| Dir | 40.0K | - | - | |
| Dir | 40.0K | - | - | |
| Dir | 40.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Sandborn William J.91 | See Remarks | Sale+OE | 11,900 | $37.16 | $442,261.12 | -19.7% | -61.2% | -93.8% | |
| Jul 31, 2023 | Subramaniam Somu89 | Director, 10% Owner | Sell | 11,414 | $37.58 | $428,967.74 | - | -61.2% | -93.8% | |
| Jul 31, 2023 | Nsv Partners III LP89 | 10% Owner | Sell | 11,414 | $37.58 | $428,967.74 | - | -61.2% | -93.8% | |
| Jul 25, 2023 | Auster Martin85 | Chief Financial Officer | Sale+OE | 28,000 | $35.54 | $995,044.40 | -37.0% | -55.8% | -92.0% | |
| Jul 12, 2023 | Subramaniam Somu89 | Director, 10% Owner | Sell | 31,921 | $37.55 | $1,198,630.20 | -0.2% | -37.0% | -93.0% | |
| Jul 12, 2023 | Nsv Partners III LP89 | 10% Owner | Sell | 31,921 | $37.55 | $1,198,630.20 | -0.2% | -37.0% | -93.0% | |
| Jul 7, 2023 | Subramaniam Somu89 | Director, 10% Owner | Sell | 100,000 | $35.23 | $3,523,056.76 | -0.3% | -15.2% | -93.8% | |
| Jul 7, 2023 | Nsv Partners III LP89 | 10% Owner | Sell | 100,000 | $35.23 | $3,523,056.76 | -0.3% | -15.2% | -93.8% | |
| Jul 5, 2023 | Mohan Raju83 | Chief Executive Officer | Sale+OE | 30,000 | $38.37 | $1,151,227.49 | -0.5% | -20.1% | -94.2% | |
| Jul 3, 2023 | Nuss John79 | Chief Scientific Officer | Sale+OE | 20,000 | $39.58 | $791,637.09 | -1.3% | -22.6% | -94.7% |